Andrew Allen - Jun 1, 2023 Form 3 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Director
Signature
/s/ Andrew R Allen**
Stock symbol
ADAP
Transactions as of
Jun 1, 2023
Transactions value $
$0
Form type
3
Date filed
6/1/2023, 04:46 PM
Previous filing
Feb 6, 2023
Next filing
Jul 3, 2023

No securities are beneficially owned.